Nanomedicines design: Approaches towards the imaging and therapy of brain tumours

M Chapman; Sofia I Pascu

doi:10.4172/2157-7439.S4-006

Nanomedicines design: Approaches towards the imaging and therapy of brain tumours

M Chapman
, Sofia I Pascu

Department of Chemistry

Research output: Contribution to journal › Article › peer-review

182 Downloads (Pure)

Abstract

Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system through nanotheranostics. This simply states that a nanocarrier can be designed in an ‘all-in-one’ approach to facilitate both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus on cancerous tumours in the brain.

Original language	English
Article number	0006
Journal	Journal of Nanomedicine and Nanotechnology
Volume	S4
DOIs	https://doi.org/10.4172/2157-7439.S4-006
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.4172/2157-7439.S4-006

Pascu_JNMNT_2012.pdf
© 2012 Chapman M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Final published version, 3.29 MBLicence: CC BY

Cite this

@article{79760a18af2d4b4e9765dc92da6161ca,

title = "Nanomedicines design: Approaches towards the imaging and therapy of brain tumours",

abstract = "Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system through nanotheranostics. This simply states that a nanocarrier can be designed in an {\textquoteleft}all-in-one{\textquoteright} approach to facilitate both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus on cancerous tumours in the brain.",

author = "M Chapman and Pascu, \{Sofia I\}",

year = "2012",

doi = "10.4172/2157-7439.S4-006",

language = "English",

volume = "S4",

journal = "Journal of Nanomedicine and Nanotechnology",

issn = "2157-7439",

publisher = "OMICS Publishing Group",

}

TY - JOUR

T1 - Nanomedicines design

T2 - Approaches towards the imaging and therapy of brain tumours

AU - Chapman, M

AU - Pascu, Sofia I

PY - 2012

Y1 - 2012

N2 - Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system through nanotheranostics. This simply states that a nanocarrier can be designed in an ‘all-in-one’ approach to facilitate both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus on cancerous tumours in the brain.

AB - Nanotechnology has potential to revolutionize diagnosis and therapy of diseases in the central nervous system through nanotheranostics. This simply states that a nanocarrier can be designed in an ‘all-in-one’ approach to facilitate both the functions of a diagnostic and a therapeutic drug. There are many challenges that must be overcome for these nanocarriers to become a successful design, but if resolved nanocarriers could pave the way for personalised medicine. This review highlights several new ideas behind nanotheranostics design and testing with a particular focus on cancerous tumours in the brain.

UR - http://dx.doi.org/10.4172/2157-7439.S4-006

U2 - 10.4172/2157-7439.S4-006

DO - 10.4172/2157-7439.S4-006

M3 - Article

SN - 2157-7439

VL - S4

JO - Journal of Nanomedicine and Nanotechnology

JF - Journal of Nanomedicine and Nanotechnology

M1 - 0006

ER -

Nanomedicines design: Approaches towards the imaging and therapy of brain tumours

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this